The Effect of Sacubitril-Valsartan on Ventricular Arrhythmia Burden in Patients With Heart Failure With Reduced Ejection Fraction

Introduction Heart failure with reduced ejection fraction (HFrEF) patients are prone to developing ventricular arrhythmias. In the PARADIGM-HF trial, sacubitril-valsartan (SV) showed a reduction in the composite endpoint of death and HF hospitalization in HFrEF patients; subgroup analysis of this tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Medeiros, Paulo, Coelho, Cláudia, Costa-Oliveira, Cátia, Rocha, Sérgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984117/
https://www.ncbi.nlm.nih.gov/pubmed/36874318
http://dx.doi.org/10.7759/cureus.34508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984117/
https://www.ncbi.nlm.nih.gov/pubmed/36874318
http://dx.doi.org/10.7759/cureus.34508

Ejemplares similares